Mark S. Gelder
Overview
Mark S. Gelder received $678K in total compensation, including $425K in salary, at Onconova Therapeutics in 2022. Mark Gelder also received $2M at Heron Therapeutics in 2012.
Source: SEC filings on June 7, 2023 and May 9, 2013.
Related executives
We found 28 more executives who work or worked at Onconova Therapeutics and Heron Therapeutics.
Craig Collard
Heron Therapeutics
Chief Executive Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
Steven Fruchtman
Onconova Therapeutics
Chief Executive Officer
Mark Guerin
Onconova Therapeutics